Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kaitlin Neary

Foot and Ankle Surgery Boise, ID Medical Doctor

NPI 1053609073 CMS profile 92956

8950 W Emerald St Ste 168, Boise, ID 83704

Open in the dashboard

General payments

$866,530

703 records reported · program years 2019–2025

Research payments

$31,018

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$203

1 holding reported · through program year 2025

Through program year 2025, Kaitlin Neary of Boise, ID is reported in the CMS Open Payments database as having received $866,530 across 703 general payments and $31,018 in research payments paid to them. They also declared ownership or investment interests valued at $203 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $270,493 115
2024 General $96,380 106
2023 General $209,048 169
2022 General $194,524 157
2021 General $76,119 90
2020 General $14,860 37
2020 Research $31,018 1
2019 General $5,106 29
2025 Ownership $203 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kaitlin Neary
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to Kaitlin Neary were reported at $270,493. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year Kaitlin Neary Foot and Ankle Surgery median Middle half National median
2019 $5,106 $1,327 $279–$5,421 $163
2020 $14,860 $795 $121–$3,473 $114
2021 $76,119 $1,289 $201–$4,963 $132
2022 $194,524 $1,539 $270–$6,067 $149
2023 $209,048 $1,117 $257–$5,264 $160
2024 $96,380 $1,064 $235–$4,944 $164
2025 $270,493 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $856,601 613 payments
  2. Steelhead Surgical Inc $6,049 40 payments
  3. Stryker Corporation $1,027 20 payments
  4. Evolution Surgical, Inc $552 4 payments
  5. Joint Restoration Foundation, Inc. $384 2 payments
  6. restor3d, inc. $374 1 payment
  7. Sawtooth Surgical Solutions Inc $371 7 payments
  8. Vilex in Tennessee, Inc. $176 1 payment
  9. Saxum Surgical, Inc. $164 1 payment
  10. MedShape, Inc. $159 2 payments
  11. Other $673 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $621,375 76 payments
  2. Consulting Fee $157,421 103 payments
  3. Travel and Lodging $71,013 164 payments
  4. Food and Beverage $14,509 357 payments
  5. Education $2,213 3 payments
Products named General payments · program years 2019–2025
  1. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE IB LIGAMENT AUGMENTATION $11,084 10 payments
  2. Arthrex $7,346 2 payments
  3. DISTAL EXTREMITIES IMPLANTS TIGHTROPE SYNDESMOSIS $1,500 1 payment
  4. DISTAL EXTREMITIES INSTRUMENTS TRAUMA HINDFOOT & ANKLE TRAUMA $850 1 payment
  5. DISTAL EXTREMITIES IMPLANTS TRAUMA EXTERNAL FIXATION $638 1 payment
  6. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ANCHORS $504 3 payments
  7. DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE EXTERNAL FIXATION $425 1 payment
  8. DISTAL EXTREMITIES IMPLANTS TENODESIS OTHER $425 2 payments
  9. DISTAL EXTREMITIES INSTRUMENTS FOOT & ANKLE DYNANITE $349 5 payments
  10. ACCULIF $247 2 payments
  11. Other $2,840 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Arthrex, Inc. $31,018 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

146

Median for Orthopedic Surgery: 203

Drug cost

$1,185

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 47 $752
Oxycodone Hcl Generic 45 $201
Tramadol Hcl Generic 38 $117
Doxycycline Hyclate Generic 16 $116

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$78,639

Of which drugs: $109

Medicare patients

160

Average age 72

Services billed

1,357

102 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 53%
Depression 21%
Osteoporosis 18%
Diabetes 15%
Atrial fibrillation 12%
Cancer 12%
Chronic kidney disease 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

704 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record